According to The Block, the new governor of the Bank of Korea, Shin Hyun-song, delivered an inaugural speech promising to promote the development of central bank digital currency (CBDC) and deposit tokens, and will expand related applications through the "Han River Project" Phase Two, while participating in global collaborations such as Project Agora to strengthen the position of the Korean won in the global payment system.
It is noteworthy that Shin Hyun-song did not mention the Korean won stablecoin in his speech, despite South Korean legislators actively advancing the "Digital Asset Basic Law" to establish a legal framework for stablecoins, with discussions expected to resume after the regional elections on June 3. Previously, during his tenure at the Bank for International Settlements (BIS), Shin held a negative attitude towards stablecoins, believing that stablecoins could not replace currency, but it has been reported that his stance has changed, stating that the Korean won stablecoin should coexist with CBDC.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.


Key Takeaways: New Governor Hyun-Song Shin supports CBDCs and tokenized deposits but omits stablecoins from his agenda. The…


Key Takeaways The Bank of Japan (BOJ) is pioneering the use of blockchain for central bank reserve settlements,…

Key Takeaways The Bank of Japan (BOJ) is leading the way as the first G7 member to explore…

Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.









Key Takeaways: New Governor Hyun-Song Shin supports CBDCs and tokenized deposits but omits stablecoins from his agenda. The…
Key Takeaways The Bank of Japan (BOJ) is pioneering the use of blockchain for central bank reserve settlements,…
Key Takeaways The Bank of Japan (BOJ) is leading the way as the first G7 member to explore…
Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.